A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...

A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat ...

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with ...

New research suggests that multiple sclerosis may begin influencing patients’ health far earlier than previously recognized. Multiple sclerosis (MS) is often recognized only after unmistakable ...

Cerebral palsy is a condition usually caused by brain damage before or during birth, resulting in impaired posture and movement. Early symptoms are typically subtle, which may delay diagnosis until ...

Researchers found that stem cells derived from human baby teeth improved motor skills, learning and brain repair in rats with ...

A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial ...

FRAXA's early preclinical support helped establish the calcium-activated potassium ("BK") channel modulator mechanism behind SPG601. FRAXA also supported the development of another BK channel ...

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome ...

Explore groundbreaking research on cerebral palsy treatments that could offer new hope for affected children and families.

Cerebral palsy is a condition usually caused by brain damage before or during birth, resulting in impaired posture and movement. A Japanese research team has demonstrated in rat experiments that stem ...